Search Medical Condition
Please enter condition
Please choose location

Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (506) clinical trials

People who have Fatty Liver Disease are asked to participate in a research study being conducted by North Shore University Hospital

Phase N/A

People who have Nonalcoholic Steatohepatitis (NASH) and cirrhosis (F4 fibrosis) are asked to participate in a research study being conducted by North Shore University Hospital

Phase N/A

People who have Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

A stage 1, prospective, randomized, placebo-controlled, double-blind study to evaluate the safety and efficacy of Alpha 1-proteinase Inhibitor (A1P1) augmentation therapy in subjects with A1P1 Deficiency and chronic obstructive pulmonary disease (COPD). This study is an approximately 2 year study that will evaluate the safety and effectiveness of the FDA ...

Phase N/A

People who have Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) are asked to participate in a research study being conducted by Montefiore Medical Center

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. ClinSearch is enrolling volunteers with NASH in a study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. Wake Research Associates is enrolling volunteers in a study testing the effectiveness, and safety of an investigational medication for individuals with NASH and associated bridging fibrosis.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. If you have a condition called compensated cirrhosis from NASH, Wake Research Associates is enrolling volunteers in a study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

Living with Liver Disorder? Wake Research Associates is enrolling volunteers with fatty liver disease or non-alcoholic steatohepatitis (NASH) in a clinical research study.

Phase N/A

Nonalcoholic steatohepatitis (NASH) is an advanced form of fatty liver disease. It is caused by excess fat in the liver that leads to inflammation and tissue injury. People with type 2 diabetes, obesity, high cholesterol, insulin resistance, and high blood pressure may have NASH. ACRC Trials is conducting a research ...

Phase